Abstract
Acute erythroid leukemia was diagnosed in a 4-month-old boy. Cytogenetic analysis of bone marrow (BM) cells showed a t(11;20)(p11;q11) translocation. RNA extracted from the BM was sequenced and analyzed for fusion transcripts using the software FusionMap. A ZMYND8-RELA fusion was ranked first. RT-PCR and direct sequencing verified the presence of an in frame ZMYND8-RELA chimeric transcript. Fluorescence in situ hybridization showed that the ZMYND8-RELA was located on the p12 band of der(11); therefore a cytogenetically invisible pericentric inversion in chromosome 11 must have taken place besides the translocation. The putative ZMYND8-RELA fusion protein contains the Zinc-PHD finger domain, a bromodomain, a PWWP domain, a MYND type of zinc finger of ZMYND8, and the entire RELA protein, indicating that it might act leukemogenically by influencing several cellular processes including the NF-kappa-B pathway.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Base Sequence
-
Chromosomes, Artificial, Bacterial / genetics
-
Humans
-
In Situ Hybridization, Fluorescence
-
Infant
-
Leukemia, Erythroblastic, Acute / genetics*
-
Male
-
Molecular Sequence Data
-
Nuclear Proteins / chemistry
-
Nuclear Proteins / genetics*
-
Oncogene Proteins, Fusion / chemistry
-
Oncogene Proteins, Fusion / genetics*
-
Protein Structure, Tertiary
-
Reverse Transcriptase Polymerase Chain Reaction
-
Transcription Factor RelA / chemistry
-
Transcription Factor RelA / genetics*
Substances
-
Nuclear Proteins
-
Oncogene Proteins, Fusion
-
RELA protein, human
-
Transcription Factor RelA
-
ZMYND8-RELA fusion protein, human
Grants and funding
The study was supported by grants from the Norwegian Cancer Society and the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.